Related Experiment Video
Updated: Jan 21, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Effects of miR-150 on neuropathic pain process via targeting AKT3
Wei Cai1, Yang Zhang2, Yan Liu2
1Department of Orthopedics, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, Huai'an Jiangsu, China.
Abstract:
MicroRNAs (miRNA) are reported to be a vital regulator of neuropathic pain. Even so, the molecular mechanisms of miRNA function on neuropathic pain development are known little. Our research was designed to investigate the role of miRNA in neuropathic pain development in rat modle set up by chronic sciatic nerve injury (CCI). Increasing miR-150 expression could significantly alleviate neuropathic pain in CCI rats. For farther researching the regulation mechanism of miR-150 on neuropathic pain, we screened AKT3 as a possible target of miR-150 by bioinformatic mechods and predicted a possible target of miR-150 in 3'-untranslated region (UTR) of AKT3 who serves as an oncogene. In rat model, the expression both of AKT3 mRNA and protein were significantly upregulated. The overexpressed miR-150 importantly repressed the level of AKT3 and simultaneously alleviate mechanical and thermal hyperalgesia in rat model. These suppressant impacts of miR-150 on neuropathic pain process can be reversed by the overexpression of AKT3. Considering all above results, our research declared that miR-150 can restrain neuropathic pain process though targeting AKT3 in vivo, suggesting that miR-150 could be the therapeutic target for neuropathic pain therapy by regulating AKT3.
Insights
MicroRNAs (miRNAs) can alleviate neuropathic pain. Our study shows miR-150 targets AKT3 to reduce pain in a rat model, suggesting miR-150 as a therapeutic target for neuropathic pain.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuropathic pain is a debilitating condition with limited treatment options.
- MicroRNAs (miRNAs) are implicated in pain regulation, but their specific roles remain unclear.
- Understanding miRNA mechanisms is crucial for developing novel pain therapies.
Purpose of the Study:
- To investigate the role of miR-150 in neuropathic pain development.
- To identify molecular targets of miR-150 in the context of pain.
- To explore the therapeutic potential of miR-150 for neuropathic pain.
Main Methods:
- A rat model of neuropathic pain was established using chronic sciatic nerve injury (CCI).
- Bioinformatic analysis was used to predict potential miRNA targets.
- miR-150 expression levels and its target AKT3 (mRNA and protein) were quantified in vivo.
- Pain behaviors (mechanical and thermal hyperalgesia) were assessed.
Main Results:
- Increased miR-150 expression significantly alleviated neuropathic pain in CCI rats.
- AKT3 was identified as a direct target of miR-150.
- Overexpression of miR-150 repressed AKT3 expression and reduced pain sensitivity.
- The pain-alleviating effects of miR-150 were reversed by AKT3 overexpression.
Conclusions:
- miR-150 restrains neuropathic pain by targeting AKT3 in vivo.
- This study highlights miR-150 as a potential therapeutic target for neuropathic pain.
- Targeting the miR-150/AKT3 pathway offers a promising strategy for pain management.
More Related Videos
10:52Chronic Constriction Injury of the Rat's Infraorbital Nerve IoN-CCI to Study Trigeminal Neuropathic Pain
Published on: September 21, 2015
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Pain
Framing Effects
Analgesia and Pain Management
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Biological Effects of Radiation
Processes of Self-Presentation